These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11712467)

  • 1. Variability in St. John's wort formulations is an important consideration.
    Kroll DJ; Shaw HS; Wall ME; Oberlies NH
    Altern Ther Health Med; 2001; 7(6):21-2. PubMed ID: 11712467
    [No Abstract]   [Full Text] [Related]  

  • 2. St. John's Wort: is it effective and harmless?
    Biron CR
    RDH; 1999 Jun; 19(6):74-6. PubMed ID: 10895712
    [No Abstract]   [Full Text] [Related]  

  • 3. St. John's wort.
    Lawvere S; Mahoney MC
    Am Fam Physician; 2005 Dec; 72(11):2249-54. PubMed ID: 16342849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperforin in extracts of St John's wort (Hypericum perforatum) for depression.
    Vormfelde SV; Poser W
    Arch Intern Med; 2000 Sep; 160(16):2548-9. PubMed ID: 10979074
    [No Abstract]   [Full Text] [Related]  

  • 5. Determining hyperforin and hypericin content in eight brands of St. John's wort.
    de los Reyes GC; Koda RT
    Am J Health Syst Pharm; 2002 Mar; 59(6):545-7. PubMed ID: 11908248
    [No Abstract]   [Full Text] [Related]  

  • 6. [Charge conformity and biopharmaceutic characterization. St. John's Wort extract preparations in comparison].
    Wurglics M; Schubert-Zsilavecz M
    Pharm Unserer Zeit; 2003; 32(3):236-41. PubMed ID: 12784544
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hypericin and hyperforin: bioactive components of St. John's Wort (Hypericum perforatum). Their isolation, analysis and study of physiological effect].
    Vacek J; Klejdus B; Kubán V
    Ceska Slov Farm; 2007 Apr; 56(2):62-6. PubMed ID: 17619301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor.
    Moore LB; Goodwin B; Jones SA; Wisely GB; Serabjit-Singh CJ; Willson TM; Collins JL; Kliewer SA
    Proc Natl Acad Sci U S A; 2000 Jun; 97(13):7500-2. PubMed ID: 10852961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. St John's wort: Prozac from the plant kingdom.
    Di Carlo G; Borrelli F; Ernst E; Izzo AA
    Trends Pharmacol Sci; 2001 Jun; 22(6):292-7. PubMed ID: 11395157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional induction and de-induction of P-glycoprotein by St. John's wort and its ingredients in a human colon adenocarcinoma cell line.
    Tian R; Koyabu N; Morimoto S; Shoyama Y; Ohtani H; Sawada Y
    Drug Metab Dispos; 2005 Apr; 33(4):547-54. PubMed ID: 15640377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phytotherapy: rarely mentioned spontaneously.
    Prescrire Int; 2006 Apr; 15(82):63. PubMed ID: 16604744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the St. John's wort constituent hyperforin on docetaxel metabolism by human hepatocyte cultures.
    Komoroski BJ; Parise RA; Egorin MJ; Strom SC; Venkataramanan R
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6972-9. PubMed ID: 16203790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Formulation of St. John's wort extract. A medicinal obstacle course].
    Schmidt PC
    Pharm Unserer Zeit; 2003; 32(3):203-11. PubMed ID: 12784540
    [No Abstract]   [Full Text] [Related]  

  • 14. Hyperforin and its analogues inhibit CYP3A4 enzyme activity.
    Lee JY; Duke RK; Tran VH; Hook JM; Duke CC
    Phytochemistry; 2006 Dec; 67(23):2550-60. PubMed ID: 17083953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of hyperforin, the active constituent of St. John's wort, in human liver microsomes.
    Hokkanen J; Tolonen A; Mattila S; Turpeinen M
    Eur J Pharm Sci; 2011 Feb; 42(3):273-84. PubMed ID: 21168483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. St John's Wort: effect on CYP3A4 activity.
    Roby CA; Anderson GD; Kantor E; Dryer DA; Burstein AH
    Clin Pharmacol Ther; 2000 May; 67(5):451-7. PubMed ID: 10824623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial activity of hyperforin from St John's wort, against multiresistant Staphylococcus aureus and gram-positive bacteria.
    Schempp CM; Pelz K; Wittmer A; Schöpf E; Simon JC
    Lancet; 1999 Jun; 353(9170):2129. PubMed ID: 10382704
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hyperforin in St. John's wort--drug, extraction and preparations].
    Lang F; Biber A; Erdelmeier C
    Pharm Unserer Zeit; 2002; 31(5):512-4. PubMed ID: 12369170
    [No Abstract]   [Full Text] [Related]  

  • 19. St John's Wort and literature quotations.
    Mennini T; Gobbi M; Morazzoni P
    Arch Intern Med; 2001 Apr; 161(7):1016-7. PubMed ID: 11295979
    [No Abstract]   [Full Text] [Related]  

  • 20. The main components of St John's Wort inhibit low-density lipoprotein atherogenic modification: a beneficial "side effect" of an OTC antidepressant drug?
    Laggner H; Schreier S; Hermann M; Exner M; Mühl A; Gmeiner BM; Kapiotis S
    Free Radic Res; 2007 Feb; 41(2):234-41. PubMed ID: 17364950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.